These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 30402905)

  • 1. Androgen Deprivation Therapy Use Increases the Risk of Heart Failure in Patients With Prostate Cancer: A Population-Based Cohort Study.
    Kao HH; Kao LT; Li IH; Pan KT; Shih JH; Chou YC; Wu ST
    J Clin Pharmacol; 2019 Mar; 59(3):335-343. PubMed ID: 30402905
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk of developing hypertension after hormone therapy for prostate cancer: a nationwide propensity score-matched longitudinal cohort study.
    Wu YH; Jhan JH; Ke HL; Tseng SI; Chang YH; Yeh HC; Li CC; Lee YC
    Int J Clin Pharm; 2020 Dec; 42(6):1433-1439. PubMed ID: 32951178
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Androgen deprivation therapy did not increase the risk of Alzheimer's and Parkinson's disease in patients with prostate cancer.
    Chung SD; Lin HC; Tsai MC; Kao LT; Huang CY; Chen KC
    Andrology; 2016 May; 4(3):481-5. PubMed ID: 27062333
    [TBL] [Abstract][Full Text] [Related]  

  • 4. No increased risk of coronary heart disease for patients receiving androgen deprivation therapy for prostate cancer in Chinese/Taiwanese men.
    Wang LH; Liu CK; Chen CH; Kao LT; Lin HC; Huang CY
    Andrology; 2016 Jan; 4(1):128-32. PubMed ID: 26711703
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risks of Major Long-Term Side Effects Associated with Androgen-Deprivation Therapy in Men with Prostate Cancer.
    Nguyen C; Lairson DR; Swartz MD; Du XL
    Pharmacotherapy; 2018 Oct; 38(10):999-1009. PubMed ID: 30080934
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Androgen deprivation therapy and the risk of iron-deficiency anaemia among patients with prostate cancer: a population-based cohort study.
    Wu FJ; Li IH; Chien WC; Shih JH; Lin YC; Chuang CM; Cheng YD; Kao LT
    BMJ Open; 2020 Mar; 10(3):e034202. PubMed ID: 32213519
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of comorbidities in men with prostate cancer treated with androgen deprivation therapy: an Australian population-based cohort study.
    Ng HS; Koczwara B; Roder D; Vitry A
    Prostate Cancer Prostatic Dis; 2018 Sep; 21(3):403-410. PubMed ID: 29720722
    [TBL] [Abstract][Full Text] [Related]  

  • 8. No increased risk of dementia in patients receiving androgen deprivation therapy for prostate cancer: a 5-year follow-up study.
    Kao LT; Lin HC; Chung SD; Huang CY
    Asian J Androl; 2017; 19(4):414-417. PubMed ID: 27232853
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risks of Serious Toxicities from Intermittent versus Continuous Androgen Deprivation Therapy for Advanced Prostate Cancer: A Population Based Study.
    Tsai HT; Pfeiffer RM; Philips GK; Barac A; Fu AZ; Penson DF; Zhou Y; Potosky AL
    J Urol; 2017 May; 197(5):1251-1257. PubMed ID: 27993663
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New-onset diabetes after androgen-deprivation therapy for prostate cancer: A nationwide propensity score-matched four-year longitudinal cohort study.
    Jhan JH; Yeh HC; Chang YH; Guu SJ; Wu WJ; Chou YH; Li CC
    J Diabetes Complications; 2018 Jul; 32(7):688-692. PubMed ID: 29909141
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between androgen deprivation therapy and community-acquired respiratory infections in patients with prostate cancer.
    Schmid M; Hanske J; Ravi P; Krishna N; Reznor G; Meyer CP; Fisch M; Noldus J; Nguyen PL; Trinh QD
    Int J Urol; 2016 Apr; 23(4):305-11. PubMed ID: 26763083
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diabetes and cardiovascular disease during androgen deprivation therapy: observational study of veterans with prostate cancer.
    Keating NL; O'Malley AJ; Freedland SJ; Smith MR
    J Natl Cancer Inst; 2010 Jan; 102(1):39-46. PubMed ID: 19996060
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is androgen deprivation therapy associated with cerebral infarction in patients with prostate cancer? A Korean nationwide population-based propensity score matching study.
    Tae BS; Jeon BJ; Choi H; Bae JH; Park JY
    Cancer Med; 2019 Aug; 8(9):4475-4483. PubMed ID: 31183968
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Androgen deprivation therapy and the risk of tenosynovitis in prostate cancer patients.
    Liu JM; Liu DW; Chuang HC; Wu CT; Lin CY; Hsu RJ
    Int Urol Nephrol; 2019 Jul; 51(7):1113-1119. PubMed ID: 31111393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between ischaemic bowel syndromes and androgen deprivation therapy in patients with prostate cancer: a retrospective cohort study.
    Chiang IN; Huang CY; Pu YS; Chang CH; Muo CH; Chung CJ; Wang RY; Young TH
    BMJ Open; 2017 Feb; 7(2):e012950. PubMed ID: 28246133
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Androgen Deprivation Therapy and the Risk of Anemia in Men with Prostate Cancer.
    Hicks BM; Klil-Drori AJ; Yin H; Campeau L; Azoulay L
    Epidemiology; 2017 Sep; 28(5):712-718. PubMed ID: 28768300
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk of colorectal cancer in men on long-term androgen deprivation therapy for prostate cancer.
    Gillessen S; Templeton A; Marra G; Kuo YF; Valtorta E; Shahinian VB
    J Natl Cancer Inst; 2010 Dec; 102(23):1760-70. PubMed ID: 21068432
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Statin reduces the risk of dementia in diabetic patients receiving androgen deprivation therapy for prostate cancer.
    Liu JM; Chen TH; Chuang HC; Wu CT; Hsu RJ
    Prostate Cancer Prostatic Dis; 2019 May; 22(2):276-283. PubMed ID: 30337635
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased risk of a herpes zoster attack in patients receiving androgen deprivation therapy for prostate cancer.
    Wu FJ; Kao LT; Sheu SY; Lin HC; Chung SD
    Andrologia; 2018 Mar; 50(2):. PubMed ID: 28786220
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diabetes and cardiovascular disease during androgen deprivation therapy for prostate cancer.
    Keating NL; O'Malley AJ; Smith MR
    J Clin Oncol; 2006 Sep; 24(27):4448-56. PubMed ID: 16983113
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.